A detailed history of Ars Investment Partners, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Ars Investment Partners, LLC holds 48,427 shares of JNJ stock, worth $7.09 Million. This represents 0.84% of its overall portfolio holdings.

Number of Shares
48,427
Previous 47,763 1.39%
Holding current value
$7.09 Million
Previous $7.49 Million 2.32%
% of portfolio
0.84%
Previous 0.89%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 02, 2024

BUY
$155.22 - $162.74 $103,066 - $108,059
664 Added 1.39%
48,427 $7.66 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $513,094 - $559,893
3,524 Added 7.97%
47,763 $7.49 Million
Q3 2023

Nov 13, 2023

BUY
$155.75 - $174.48 $128,026 - $143,422
822 Added 1.89%
44,239 $6.89 Million
Q2 2023

Jul 11, 2023

BUY
$154.35 - $166.11 $5.48 Million - $5.9 Million
35,498 Added 448.26%
43,417 $7.19 Million
Q1 2023

Apr 05, 2023

BUY
$151.05 - $180.26 $109,209 - $130,327
723 Added 10.05%
7,919 $1.23 Million
Q4 2022

Jan 25, 2023

SELL
$160.2 - $179.79 $305,020 - $342,320
-1,904 Reduced 20.92%
7,196 $0
Q3 2022

Oct 07, 2022

BUY
$161.33 - $179.52 $215,214 - $239,479
1,334 Added 17.18%
9,100 $1.49 Million
Q2 2022

Jul 15, 2022

BUY
$168.19 - $186.01 $49,616 - $54,872
295 Added 3.95%
7,766 $1.38 Million
Q4 2021

Feb 11, 2022

SELL
$155.93 - $173.01 $5.93 Million - $6.58 Million
-38,022 Reduced 83.58%
7,471 $1.28 Million
Q3 2021

Nov 05, 2021

SELL
$161.5 - $179.47 $265,183 - $294,689
-1,642 Reduced 3.48%
45,493 $7.35 Million
Q2 2021

Aug 06, 2021

BUY
$159.48 - $171.07 $162,031 - $173,807
1,016 Added 2.2%
47,135 $7.77 Million
Q1 2021

May 13, 2021

BUY
$153.07 - $170.48 $108,679 - $121,040
710 Added 1.56%
46,119 $7.58 Million
Q4 2020

Feb 09, 2021

SELL
$137.11 - $157.38 $5.14 Million - $5.91 Million
-37,524 Reduced 45.25%
45,409 $7.15 Million
Q3 2020

Nov 12, 2020

BUY
$140.38 - $153.83 $76,647 - $83,991
546 Added 0.66%
82,933 $12.3 Million
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $10.6 Million - $12.8 Million
82,387 New
82,387 $11.6 Million
Q1 2020

May 12, 2020

SELL
$111.14 - $153.99 $803,208 - $1.11 Million
-7,227 Closed
0 $0
Q4 2019

Feb 12, 2020

SELL
$127.5 - $146.44 $1.26 Million - $1.44 Million
-9,851 Reduced 57.68%
7,227 $1.05 Million
Q3 2019

Nov 14, 2019

SELL
$126.95 - $142.14 $637,542 - $713,827
-5,022 Reduced 22.72%
17,078 $2.21 Million
Q2 2019

Aug 12, 2019

BUY
$131.15 - $144.24 $521,845 - $573,930
3,979 Added 21.96%
22,100 $3.08 Million
Q1 2019

May 09, 2019

SELL
$125.72 - $139.79 $175,630 - $195,286
-1,397 Reduced 7.16%
18,121 $2.53 Million
Q4 2018

Feb 13, 2019

BUY
$122.84 - $147.84 $40,291 - $48,491
328 Added 1.71%
19,518 $2.52 Million
Q3 2018

Nov 13, 2018

BUY
$121.58 - $142.88 $36,352 - $42,721
299 Added 1.58%
19,190 $2.65 Million
Q2 2018

Aug 13, 2018

SELL
$119.4 - $131.76 $12,298 - $13,571
-103 Reduced 0.54%
18,891 $2.29 Million
Q1 2018

May 04, 2018

SELL
$125.1 - $148.14 $36,529 - $43,256
-292 Reduced 1.51%
18,994 $2.43 Million
Q4 2017

Feb 14, 2018

SELL
$131.22 - $143.62 $95,134 - $104,124
-725 Reduced 3.62%
19,286 $2.7 Million
Q3 2017

Nov 14, 2017

BUY
$129.47 - $135.38 $2.59 Million - $2.71 Million
20,011
20,011 $2.6 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $383B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Ars Investment Partners, LLC Portfolio

Follow Ars Investment Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ars Investment Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ars Investment Partners, LLC with notifications on news.